Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

The Value of 18F-FDG PET in the Detection of Stage M0 Carcinoma of the Nasopharynx

Tzu-Chen Yen, Joseph Tung-Chieh Chang, Shu-Hang Ng, Yu-Chen Chang, Sheng-Chieh Chan, Kun-Ju Lin, Wuu-Jyh Lin, Ying-Kai Fu and Chen-Yu Lin
Journal of Nuclear Medicine March 2005, 46 (3) 405-410;
Tzu-Chen Yen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Tung-Chieh Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Hang Ng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Chen Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheng-Chieh Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun-Ju Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wuu-Jyh Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying-Kai Fu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen-Yu Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Flowchart of patients enrolled in this study. FP = false-positive LN = lymph node MLN = mediastinal lymph node TP = true-positive.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    18F-FDG PET and MRI scans of 42-y-old male NPC patient (undifferentiated cell type) with initial clinical stage of T1 N3b M0. Result of whole-body bone scan was negative (A). Unexpected L1–2 spine metastatic lesion was found on whole-body 18F-FDG PET scan (B, arrow) and later confirmed by MRI (C, arrow).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    18F-FDG PET and CT scans of 29-y-old male NPC patient (poorly differentiated squamous cell type) with initial clinical stage of T3 N1 M0. Initial 18F-FDG PET scan showed huge tumor in nasopharyngeal roof, with metastases to lymph nodes in left upper and lower neck. No definite evidence of mediastinal lymph node metastasis was noted (A). Three months after definitive concurrent chemoradiotherapy, follow-up 18F-FDG PET showed complete remission of primary and metastatic lesions in left neck. However, equivocal mediastinal lymph node metastatic lesions were noted on both 18F-FDG PET scans and chest CT scans (B and C). Further follow-up 18F-FDG PET scans and chest CT scans showed no evidence of lymphadenopathy in mediastinal region (D and E). Findings shown in B can therefore be considered false-positive after concurrent chemoradiotherapy.

Tables

  • Figures
    • View popup
    TABLE 1

    Comparison of Demographics and Disease Characteristics Between Primary NPC Patients With Distant Metastasis and Their Counterparts Without Distant Metastasis

    CharacteristicPatients with distant metastasis (n = 14)Patients without distant metastasis (n = 104)All patients (n = 118)P
    Age (y)53.07 ± 11.6649.22 ± 12.849.68 ± 12.680.288*
    Sex0.221†
        Male126880
        Female23638
    Cell type (n = 91)§1.000†
        Nonkeratinized or poorly differentiated carcinoma53641
        Undifferentiated carcinoma96877
    Tumor stage0.923‡
        T1–285866
        T3–464652
    Nodal stage0.044†
        N1 or less24547
        N2 or greater125971
    0.008†
        N2 or less892100
        N361218
    • ↵* Independent t test.

    • ↵† Fisher exact test.

    • ↵‡ χ2 test.

    • ↵§ One patient with adenoid cystic carcinoma is excluded.

    • View popup
    TABLE 2

    Comparison of Demographics and Disease Characteristics Between Relapsed NPC Patients With Distant Metastasis and Their Counterparts Without Distant Metastasis

    CharacteristicPatients with distant metastasis (n = 4)Patients without distant metastasis (n = 18)All patients (n = 22)P
    Age (y)45.0 ± 8.8748.72 ± 8.6848.05 ± 8.620.448*
    Sex0.535†
        Male41317
        Female055
    Cell type0.586†
        Nonkeratinized or poorly differentiated carcinoma3811
        Undifferentiated carcinoma11011
    Initial tumor stage0.582†
        T1–2189
        T3–43710
    Initial nodal stage0.616†
        N1 or less31013
        N2 or greater189
    • ↵* Independent t test.

    • ↵† Fisher exact test.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (3)
Journal of Nuclear Medicine
Vol. 46, Issue 3
March 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Value of 18F-FDG PET in the Detection of Stage M0 Carcinoma of the Nasopharynx
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Value of 18F-FDG PET in the Detection of Stage M0 Carcinoma of the Nasopharynx
Tzu-Chen Yen, Joseph Tung-Chieh Chang, Shu-Hang Ng, Yu-Chen Chang, Sheng-Chieh Chan, Kun-Ju Lin, Wuu-Jyh Lin, Ying-Kai Fu, Chen-Yu Lin
Journal of Nuclear Medicine Mar 2005, 46 (3) 405-410;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Value of 18F-FDG PET in the Detection of Stage M0 Carcinoma of the Nasopharynx
Tzu-Chen Yen, Joseph Tung-Chieh Chang, Shu-Hang Ng, Yu-Chen Chang, Sheng-Chieh Chan, Kun-Ju Lin, Wuu-Jyh Lin, Ying-Kai Fu, Chen-Yu Lin
Journal of Nuclear Medicine Mar 2005, 46 (3) 405-410;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era
  • Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging
  • The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
  • Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx
  • Differential Roles of 18F-FDG PET in Patients with Locoregional Advanced Nasopharyngeal Carcinoma After Primary Curative Therapy: Response Evaluation and Impact on Management
  • [18F]Fluorodeoxyglucose Positron Emission Tomography Is More Sensitive Than Skeletal Scintigraphy for Detecting Bone Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire